Literature DB >> 26399219

Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.

Ernest K Amankwah1,2, Hui-Yi Lin3, Jonathan P Tyrer4, Kate Lawrenson5, Joe Dennis4, Ganna Chornokur1, Katja K H Aben6,7, Hoda Anton-Culver8, Natalia Antonenkova9, Fiona Bruinsma10, Elisa V Bandera11, Yukie T Bean12,13, Matthias W Beckmann14, Maria Bisogna15, Line Bjorge16,17, Natalia Bogdanova18, Louise A Brinton19, Angela Brooks-Wilson20,21, Clareann H Bunker22, Ralf Butzow23,24, Ian G Campbell25,26,27, Karen Carty28,29, Zhihua Chen3, Y Ann Chen3, Jenny Chang-Claude30, Linda S Cook31, Daniel W Cramer32, Julie M Cunningham33, Cezary Cybulski34, Agnieszka Dansonka-Mieszkowska35, Andreas du Bois36,37, Evelyn Despierre38, Ed Dicks39, Jennifer A Doherty40,41, Thilo Dörk18, Matthias Dürst42, Douglas F Easton43,44, Diana M Eccles45, Robert P Edwards46, Arif B Ekici47, Peter A Fasching14,48, Brooke L Fridley49, Yu-Tang Gao50, Aleksandra Gentry-Maharaj51, Graham G Giles10,52, Rosalind Glasspool29, Marc T Goodman53,54, Jacek Gronwald34, Patricia Harrington39, Philipp Harter36,37, Hanis N Hasmad55, Alexander Hein14, Florian Heitz36,37, Michelle A T Hildebrandt56, Peter Hillemanns18, Claus K Hogdall57, Estrid Hogdall58,59, Satoyo Hosono60, Edwin S Iversen61, Anna Jakubowska34, Allan Jensen58, Bu-Tian Ji19, Beth Y Karlan62, Heather Jim63, Melissa Kellar12,13, Lambertus A Kiemeney6, Camilla Krakstad16,17, Susanne K Kjaer57,58, Jolanta Kupryjanczyk35, Diether Lambrechts64,65, Sandrina Lambrechts38, Nhu D Le66, Alice W Lee5, Shashi Lele67, Arto Leminen23, Jenny Lester62, Douglas A Levine15, Dong Liang68, Boon Kiong Lim69, Jolanta Lissowska70, Karen Lu71, Jan Lubinski34, Lene Lundvall57, Leon F A G Massuger72, Keitaro Matsuo60, Valerie McGuire73, John R McLaughlin74, Ian McNeish29, Usha Menon51, Roger L Milne10,52, Francesmary Modugno22,75,76, Kirsten B Moysich67, Roberta B Ness77, Heli Nevanlinna23, Ursula Eilber30, Kunle Odunsi78, Sara H Olson79, Irene Orlow79, Sandra Orsulic62, Rachel Palmieri Weber80, James Paul29, Celeste L Pearce5,81, Tanja Pejovic12,13, Liisa M Pelttari23, Jennifer Permuth-Wey1, Malcolm C Pike5,79, Elizabeth M Poole82,83, Harvey A Risch84, Barry Rosen85,86, Mary Anne Rossing41, Joseph H Rothstein73, Anja Rudolph30, Ingo B Runnebaum42, Iwona K Rzepecka35, Helga B Salvesen16,17, Eva Schernhammer82,83, Ira Schwaab87, Xiao-Ou Shu88, Yurii B Shvetsov89, Nadeem Siddiqui28, Weiva Sieh73, Honglin Song39, Melissa C Southey26, Beata Spiewankiewicz90, Lara Sucheston-Campbell67, Soo-Hwang Teo55,91, Kathryn L Terry32,83, Pamela J Thompson53,54, Lotte Thomsen92, Ingvild L Tangen16,17, Shelley S Tworoger32,83, Anne M van Altena72, Robert A Vierkant93, Ignace Vergote38, Christine S Walsh62, Shan Wang-Gohrke30, Nicolas Wentzensen19, Alice S Whittemore73, Kristine G Wicklund41, Lynne R Wilkens89, Anna H Wu5, Xifeng Wu56, Yin-Ling Woo69, Hannah Yang19, Wei Zheng94, Argyrios Ziogas8, Linda E Kelemen95, Andrew Berchuck96, Joellen M Schildkraut97, Susan J Ramus5, Ellen L Goode98, Alvaro N A Monteiro3, Simon A Gayther5, Steven A Narod99, Paul D P Pharoah43, Thomas A Sellers1, Catherine M Phelan1.   

Abstract

Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate cancer metastasis. However, EMT also contributes to the initiation and development of primary tumors. Prior studies that explored the hypothesis that EMT gene variants contribute to epithelial ovarian carcinoma (EOC) risk have been based on small sample sizes and none have sought replication in an independent population. We screened 15,816 single-nucleotide polymorphisms (SNPs) in 296 genes in a discovery phase using data from a genome-wide association study of EOC among women of European ancestry (1,947 cases and 2,009 controls) and identified 793 variants in 278 EMT-related genes that were nominally (P < 0.05) associated with invasive EOC. These SNPs were then genotyped in a larger study of 14,525 invasive-cancer patients and 23,447 controls. A P-value <0.05 and a false discovery rate (FDR) <0.2 were considered statistically significant. In the larger dataset, GPC6/GPC5 rs17702471 was associated with the endometrioid subtype among Caucasians (odds ratio (OR) = 1.16, 95% CI = 1.07-1.25, P = 0.0003, FDR = 0.19), whereas F8 rs7053448 (OR = 1.69, 95% CI = 1.27-2.24, P = 0.0003, FDR = 0.12), F8 rs7058826 (OR = 1.69, 95% CI = 1.27-2.24, P = 0.0003, FDR = 0.12), and CAPN13 rs1983383 (OR = 0.79, 95% CI = 0.69-0.90, P = 0.0005, FDR = 0.12) were associated with combined invasive EOC among Asians. In silico functional analyses revealed that GPC6/GPC5 rs17702471 coincided with DNA regulatory elements. These results suggest that EMT gene variants do not appear to play a significant role in the susceptibility to EOC.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  epithelial-mesenchymal transition; ovarian cancer; single-nucleotide polymorphisms

Mesh:

Year:  2015        PMID: 26399219      PMCID: PMC4721602          DOI: 10.1002/gepi.21921

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  35 in total

1.  Estimating local ancestry in admixed populations.

Authors:  Sriram Sankararaman; Srinath Sridhar; Gad Kimmel; Eran Halperin
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  A lung cancer gene GPC5 could also be crucial in breast cancer.

Authors:  Changwen Zhang; Shuping Zhang; Daoqiang Zhang; Zhihong Zhang; Yong Xu; Sijin Liu
Journal:  Mol Genet Metab       Date:  2011-02-12       Impact factor: 4.797

4.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

5.  Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Authors:  Claudia Prahst; Mélanie Héroult; Anthony A Lanahan; Noa Uziel; Ofra Kessler; Niva Shraga-Heled; Michael Simons; Gera Neufeld; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

6.  Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer.

Authors:  Xin Yang; Zhi Zhang; Mantang Qiu; Jingwen Hu; Xiaohu Fan; Jie Wang; Lin Xu; Rong Yin
Journal:  Cancer Lett       Date:  2013-08-17       Impact factor: 8.679

7.  The effects of common genetic variants in oncogenes on ovarian cancer survival.

Authors:  Lydia Quaye; Simon A Gayther; Susan J Ramus; Richard A Di Cioccio; Valerie McGuire; Estrid Hogdall; Claus Hogdall; Jan Blaakr; Douglas F Easton; Bruce A J Ponder; Ian Jacobs; Susanne Kruger Kjaer; Alice S Whittemore; Celeste Leigh Pearce; Paul D P Pharoah; Honglin Song
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

Review 8.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

9.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants.

Authors:  Lucas D Ward; Manolis Kellis
Journal:  Nucleic Acids Res       Date:  2011-11-07       Impact factor: 16.971

10.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

View more
  12 in total

1.  Heparan sulfate proteoglycans as targets for cancer therapy: a review.

Authors:  Jessica Oyie Sousa Onyeisi; Bianca Zaia Franco Ferreira; Helena Bonciani Nader; Carla Cristina Lopes
Journal:  Cancer Biol Ther       Date:  2020-11-12       Impact factor: 4.742

Review 2.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

3.  Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor.

Authors:  Guannan Zhao; Qinghui Wang; Zhongzhi Wu; Xinchun Tian; Huan Yan; Baojin Wang; Peixin Dong; Hidemichi Watari; Lawrence M Pfeffer; Yuqi Guo; Wei Li; Junming Yue
Journal:  Mol Cancer Ther       Date:  2019-09-12       Impact factor: 6.261

4.  TNFAIP8 variants as potential epidemiological and predictive biomarkers in ovarian cancer.

Authors:  Hongyu Gao; Zhiran Zhang; Liangliang Jiang; Lei Zhang; Ling Qin; Tianbo Liu; Shanshan Yang
Journal:  Cancer Cell Int       Date:  2020-08-17       Impact factor: 5.722

5.  Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.

Authors:  Yang Deng; Kunlin Xie; Christopher J Logothetis; Timothy C Thompson; Jeri Kim; Maosheng Huang; David W Chang; Jian Gu; Xifeng Wu; Yuanqing Ye
Journal:  Carcinogenesis       Date:  2020-08-12       Impact factor: 4.944

6.  Polymorphisms in genes related to epithelial-mesenchymal transition and risk of non-small cell lung cancer.

Authors:  Kunlin Xie; Yuanqing Ye; Yong Zeng; Jian Gu; Hushan Yang; Xifeng Wu
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

Review 7.  Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice.

Authors:  Anliang Dong; Yan Lu; Bingjian Lu
Journal:  J Cancer       Date:  2016-07-05       Impact factor: 4.207

Review 8.  The untapped potential of ascites in ovarian cancer research and treatment.

Authors:  Caroline Elizabeth Ford; Bonnita Werner; Neville Frederick Hacker; Kristina Warton
Journal:  Br J Cancer       Date:  2020-05-08       Impact factor: 7.640

9.  Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.

Authors:  Guannan Zhao; Qinghui Wang; Qingqing Gu; Wenan Qiang; Jian-Jun Wei; Peixin Dong; Hidemichi Watari; Wei Li; Junming Yue
Journal:  Oncotarget       Date:  2017-10-17

10.  miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.

Authors:  Baojin Wang; Xia Li; Guannan Zhao; Huan Yan; Peixin Dong; Hidemichi Watari; Michelle Sims; Wei Li; Lawrence M Pfeffer; Yuqi Guo; Junming Yue
Journal:  J Exp Clin Cancer Res       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.